TrialCell reports. Medicine2025

Tumor-infiltrated double-negative regulatory T cells predict outcome of T cell-based immunotherapy in nasopharyngeal carcinoma.

Xiu-Feng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.